
Johnson & Johnson Reports Strong Q2 Earnings, Raises Full-Year Forecast
Johnson & Johnson reported second-quarter earnings that surpassed Wall Street estimates, driven by the strength of its medicines unit. The company also increased its full-year sales and profit forecast, following positive results from Johnson & Johnson, PNC Financial, and Elevance Health.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (37/100)Sources
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways
Johnson & Johnson's quarter was imperfect, but enough is going right to validate our ownership of the stock.
Read full article →J&J quarterly earnings beat Wall Street estimates on strength of medicines unit
Read full article →Earnings Snapshot: Johnson & Johnson Q2 beats on top and bottom lines, hikes FY2026 guidance
Read full article →Coverage Timeline
Related Stories

South Korean Stocks Rise Nearly 1% Ahead of Nvidia Earnings
12m ago

Analysis Explores Commercial Ties Between Irish Football League and Gambling Sector
41m ago

Siemens Energy Plans Spin-Off of Industrial Division Amid Power Surge
45m ago

Rare Earth Miner Lynas Pursues New Supply Deals and U.S. Manufacturing Facility
1h ago